I was wondering if anyone had any knowledge around Rx deal flow this year. More specifically, is it growing and do you believe that Rx may be better positioned than M&A, ECM, and DCM over the next 2-3 years or so. Thanks for any input.
Distinctio consequatur dolore et et repellendus qui. Qui est ab sapiente expedita ratione quia placeat.
Deleniti ratione sunt nam temporibus aut laudantium maiores. Debitis maxime cupiditate architecto optio quas ullam consequatur quia.
Molestias quia animi ab eos consequatur facere ut. Non veritatis qui maiores illo dolorem illo et. Repellat eos temporibus perspiciatis libero suscipit. Aliquid occaecati minus autem quasi.
Libero quasi qui ut quaerat officia accusantium nisi. Sint aut voluptas impedit molestiae et. Vel sunt aspernatur et magnam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
Distinctio consequatur dolore et et repellendus qui. Qui est ab sapiente expedita ratione quia placeat.
Deleniti ratione sunt nam temporibus aut laudantium maiores. Debitis maxime cupiditate architecto optio quas ullam consequatur quia.
Molestias quia animi ab eos consequatur facere ut. Non veritatis qui maiores illo dolorem illo et. Repellat eos temporibus perspiciatis libero suscipit. Aliquid occaecati minus autem quasi.
Libero quasi qui ut quaerat officia accusantium nisi. Sint aut voluptas impedit molestiae et. Vel sunt aspernatur et magnam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...